Aqueous formulations of peptides

Details Aqueous formulations of peptides Aqueous formulations of peptides

1999-02-11

2000-05-30

Azpuru, Carlos A

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Implant or insert

A61F 202

Patent

active

060688505

ABSTRACT:
This invention relates to stable liquid aqueous formulations of peptide compounds at high concentrations. These stable formulations comprise at least about 10% peptide in water. They may be stored at elevated temperatures for long periods of time and are especially useful in implantable delivery devices for long term delivery of drug.

REFERENCES:
patent: 3914412 (1975-10-01), Gendrich et al.
patent: 4547370 (1985-10-01), Roeske
patent: 4661472 (1987-04-01), Rivier et al.
patent: 4689396 (1987-08-01), Roeske et al.
patent: 4851385 (1989-07-01), Roeske
patent: 5034229 (1991-07-01), Magruder et al.
patent: 5057318 (1991-10-01), Magruder et al.
patent: 5110596 (1992-05-01), Magruder et al.
patent: 5198533 (1993-03-01), Schally et al.
patent: 5413990 (1995-05-01), Haviv et al.
patent: 5480868 (1996-01-01), Kamei et al.
patent: 5482931 (1996-01-01), Harris et al.
patent: 5498598 (1996-03-01), Harris
Fu Lu, et al., "Percutaneous Absorption Enhancement of Leuprolide", Pharm. Res., 9(12):1575-1576 (1992).
Helm, et al., "Stability of Gonadorelin and Triptorelin in Aqueous Solution", Pharm. Res., 7(12):1253-1256 (1990).
Johnson, et al., "Degradation of the LH-RH Analog Nafarelin Acetate in Aqueous Solution", Intl. J. Pharm., 31:125-129 (1986).
Okada, et al., "Preparation of Three-Month Depot Injectable Microspheres of Leuprorelin Acetate Using Biodegradable Polymers", Pharm. Res., 11(8):1143-1147 (1994).
Okada, et al., "New Degradation Product of Des-Gly.sup.10 -NH.sub.2 -LH-RH-Ethylamide (Fertirelin) in Aqueous Solution", J. Pharm. Sci., 80(2):167-170 (1991).
Oyler, et al., "Characterization of the Solution Degradation Products of Histrelin, a Gonadotropin Releasing Hormone (LH/RH) Agonist", J. Pharm. Sci., 80(3):271-275 (1991).
Powell, et al., "Peptide Liquid Crystals: Inverse Correlation of Kinetic Formation and Thermodynamic Stability in Aqueous Solution", Pharm. Res., 11(9):1352-1354 (1994).
Powell, et al., "Parenteral Peptide Formulations: Chemical and Physical Properties of Native Luteinizing Hormone-Releasing Hormone (LHRH) and Hydrophobic Analogues in Aqueous Solution", Pharm. Res., 8(10):1258-1263 (1991).
Powers, et al., "Solution Behavior of Leuprolide Acetate, an LHRH Agonist, as Determined by Circular Dichroism Spectroscopy", Intl. J. Pharm.,108:49-55 (1994).
Shi, et al., "Long-Term Stability of Aqueous Solutions of Luteinizing Hormone-Releasing Hormone Assessed by an In-Vitro Bioassay and Liquid Chromatography", J. Pharm. Sci., 73(6):819-821 (1984).
Toguchi, "Pharmaceutical Manipulation of Leuprorelin Acetate to Improve Clinical Performance", J. Intl. Med. Res., 18:35-41 (1990).
Factrel (gonadorelin HCI for subcutaneous or IV injection), Physician's Desk Reference, 50th Edition, pp. 2877-2878 (1996).
Lupron (leuprolide acetate for subcutaneous injection), Physician's Desk Reference, 50th Edition, pp. 2555-2556 (1996).
Lupron Depot (leuprolide acetate for depot suspension), Physician's Desk Reference, 50th Edition, pp. 2556-2562 (1996).
Lutrepulse (gonadorelin acetate for IV injection), Physician's Desk Reference, 50th Edition, pp. 980-982 (1996).
Zoladex (goserelin acetate implant), Physician's Desk Reference, 50th Edition, pp. 2858-2861 (1996).

Affiliated with

Also associated with

Rating

Aqueous formulations of peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Aqueous formulations of peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aqueous formulations of peptides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1908210